tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Belite Bio completes enrollment in PHOENIX trial
PremiumThe FlyBelite Bio completes enrollment in PHOENIX trial
1M ago
Belite Bio management to meet with Maxim
Premium
The Fly
Belite Bio management to meet with Maxim
2M ago
Belite Bio’s Promising Outlook: FDA Breakthrough Designation and Upcoming Milestones Boost Buy Rating
Premium
Ratings
Belite Bio’s Promising Outlook: FDA Breakthrough Designation and Upcoming Milestones Boost Buy Rating
3M ago
Promising Clinical Trials and Strategic Developments Justify Buy Rating for Belite Bio
PremiumRatingsPromising Clinical Trials and Strategic Developments Justify Buy Rating for Belite Bio
3M ago
Belite Bio Advances Clinical Trials Amid Financial Challenges
Premium
Company Announcements
Belite Bio Advances Clinical Trials Amid Financial Challenges
3M ago
Belite Bio Advances Tinlarebant Trials with Positive Interim Results
Premium
Company Announcements
Belite Bio Advances Tinlarebant Trials with Positive Interim Results
3M ago
Belite Bio, Inc. Appoints New Auditor
PremiumCompany AnnouncementsBelite Bio, Inc. Appoints New Auditor
4M ago
Belite Bio price target raised to $80 from $79 at Benchmark
Premium
The Fly
Belite Bio price target raised to $80 from $79 at Benchmark
5M ago
Belite Bio, Inc. ADR: Promising Clinical Progress and Strong Financial Position Drive Buy Rating
Premium
Ratings
Belite Bio, Inc. ADR: Promising Clinical Progress and Strong Financial Position Drive Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100